TAFINLAR caps 50 mg bte 28 pce
7680627810010
CH-62781
L01EC02
07.16.1.
Reimbursement limitations:
TAFINLAR.01
Mélanome métastatique
Le tramétinib en association avec le dabrafénib est remboursé pour le traitement des …
1 / 3
google
Details
- Product number
- 6278101
- CPT
- -
- Packaging group
- 28
- Unit
- Kapsel(n)
- Composition
- dabrafenibum 50 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula.
Articles (1)
Tafinlar 50 mg, Hartkapseln
Kapseln
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 908.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2014
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 62781
- Drug name
- Tafinlar, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01EC02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/01/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TAFINLAR caps 50 mg bte 28 pce
- Description (DE)
- TAFINLAR Kaps 50 mg Ds 28 Stk
- Market launch
- 13/01/2014
- Narcotic (BTM)
- No